Alzheimer's Disease Drug Discovery Targeted to the APP mRNA 5'Untranslated Region

By Rogers J.T.   Randall J.D.   Eder P.S.   Huang X.   Bush A.I.   Tanzi R.E.   Venti A.   Payton S.M.   Giordano T.   Nagano S.   Cahill C.M.   Moir R.   Lahiri D.K.   Greig N.   Sarang S.S.   Gullans S.R.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 77-82

Humana Press, Inc

Access to resources Recommend Favorite

Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region: The action of paroxetine and dimercaptopropanol

By Payton Sandra   Cahill Catherine   Randall Jeffrey   Gullans Steven   Rogers Jack  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 267-275

Humana Press, Inc

Access to resources Recommend Favorite

FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein

By Morse Lee   Payton Sandra   Cuny Gregory   Rogers Jack  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 129-136

Humana Press, Inc

Access to resources Recommend Favorite

No Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes

By  

Current Alzheimer Research, Vol. 12, Iss. 1, 2015-01 ,pp. : 47-52

Bentham Science Publishers

Access to resources Recommend Favorite

The effect of amyloidosis-β and ageing on proliferation of neuronal progenitor cells in APP-transgenic mouse hippocampus and in culture

By Kolecki Radek   LaFauci Giuseppe   Rubenstein Richard   Mazur-Kolecka Bozena   Kaczmarski Wojciech   Frackowiak Janusz  

Acta Neuropathologica, Vol. 116, Iss. 4, 2008-10 ,pp. : 419-424

Springer Publishing Company

Access to resources Recommend Favorite